Citations (69)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Dandan Chen, Ping Tang, Linxiang Liu, Fang Wang, Haizhou Xing, Ling Sun & Zhongxing Jiang. (2018) Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway. Cell Cycle 17:7, pages 858-867.
Read now
Read now
Carl A. Gregory. (2007) More progress defining the crosstalk between multiple myeloma and mesenchymal stem cells of the bone marrow. Leukemia & Lymphoma 48:10, pages 1896-1897.
Read now
Read now
Articles from other publishers (67)
Lei Wang, Weijun Yi, Li Ma, Emily Lecea, Lori A. Hazlehurst, Donald A. Adjeroh & Gangqing Hu. (2023) Inflammatory Bone Marrow Mesenchymal Stem Cells in Multiple Myeloma: Transcriptional Signature and In Vitro Modeling. Cancers 15:21, pages 5148.
Crossref
Crossref
Natalya Plakhova, Vasilios Panagopoulos, Kate Vandyke, Andrew C. W. Zannettino & Krzysztof M. Mrozik. (2023) Mesenchymal stromal cell senescence in haematological malignancies. Cancer and Metastasis Reviews 42:1, pages 277-296.
Crossref
Crossref
Luca Heinemann, Klara Maria Möllers, Helal Mohammed Mohammed Ahmed, Lanying Wei, Kaiyan Sun, Subbaiah Chary Nimmagadda, Daria Frank, Anja Baumann, Alexandra M. Poos, Martin Dugas, Julian Varghese, Marc-Steffen Raab & Cyrus Khandanpour. (2022) Inhibiting PI3K–AKT–mTOR Signaling in Multiple Myeloma-Associated Mesenchymal Stem Cells Impedes the Proliferation of Multiple Myeloma Cells. Frontiers in Oncology 12.
Crossref
Crossref
Mingyang Deng, Huan Yuan, Hongling Peng, Sufang Liu, Xiang Xiao, Zhihua Wang, Guangsen Zhang & Han Xiao. (2022) Mesenchymal Stem Cells Inhibit the Effects of Dexamethasone in Multiple Myeloma Cells. Stem Cells International 2022, pages 1-12.
Crossref
Crossref
Natella I. Enukashvily, Natalia Semenova, Anna V. Chubar, Dmitry I. Ostromyshenskii, Ekaterina A. Gushcha, Sergei Gritsaev, Stanislav S. Bessmeltsev, Viktor I. Rugal, Egor M. Prikhodko, Ivan Kostroma, Anastasia Zherniakova, Anastasia V. Kotova, Liubov A. Belik, Alexander Shumeev, Irina I. Maslennikova & Dmitry I. Ivolgin. (2022) Pericentromeric Non-Coding DNA Transcription Is Associated with Niche Impairment in Patients with Ineffective or Partially Effective Multiple Myeloma Treatment. International Journal of Molecular Sciences 23:6, pages 3359.
Crossref
Crossref
Ladan Kobari, Martine Auclair, Olivier Piau, Nathalie Ferrand, Maurice Zaoui, François Delhommeau, Bruno Fève, Michèle Sabbah & Laurent Garderet. (2021) Circulating cytokines present in multiple myeloma patients inhibit the osteoblastic differentiation of adipose stem cells. Leukemia 36:2, pages 540-548.
Crossref
Crossref
Chiara Valsecchi, Stefania Croce, Alice Maltese, Lorenza Montagna, Elisa Lenta, Alice Nevone, Maria Girelli, Paolo Milani, Tiziana Bosoni, Margherita Massa, Carlotta Abbà, Rita Campanelli, Jessica Ripepi, Annalisa De Silvestri, Adriana Carolei, Giovanni Palladini, Marco Zecca, Mario Nuvolone & Maria Antonietta Avanzini. (2021) Bone Marrow Microenvironment in Light-Chain Amyloidosis: In Vitro Expansion and Characterization of Mesenchymal Stromal Cells. Biomedicines 9:11, pages 1523.
Crossref
Crossref
Natalia-Del Pilar Vanegas, Paola Fernanda Ruiz-Aparicio, Gloria Inés Uribe, Adriana Linares-Ballesteros & Jean-Paul Vernot. (2021) Leukemia-Induced Cellular Senescence and Stemness Alterations in Mesenchymal Stem Cells Are Reversible upon Withdrawal of B-Cell Acute Lymphoblastic Leukemia Cells. International Journal of Molecular Sciences 22:15, pages 8166.
Crossref
Crossref
Liu Zhaoyun & Fu Rong. (2021) Predictive Role of Immune Profiling for Survival of Multiple Myeloma Patients. Frontiers in Immunology 12.
Crossref
Crossref
Z Liu, F Mi, M Han, M Tian, L Deng, N Meng, J Luo & R Fu. (2021) Bone marrow-derived mesenchymal stem cells inhibit CD8+ T cell immune responses via PD-1/PD-L1 pathway in multiple myeloma. Clinical and Experimental Immunology 205:1, pages 53-62.
Crossref
Crossref
Patricia Maiso, Pedro Mogollón, Enrique M. Ocio & Mercedes Garayoa. (2021) Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression. Cancers 13:11, pages 2542.
Crossref
Crossref
Fulvio Massaro, Florent Corrillon, Basile Stamatopoulos, Nathalie Meuleman, Laurence Lagneaux & Dominique Bron. (2020) Aging of Bone Marrow Mesenchymal Stromal Cells: Hematopoiesis Disturbances and Potential Role in the Development of Hematologic Cancers. Cancers 13:1, pages 68.
Crossref
Crossref
Michiko Ichii & Naoki Hosen. (2020) Current Understanding of Myelomatous Mesenchymal Stromal Cells Extended through Advances in Experimental Methods. Cancers 13:1, pages 25.
Crossref
Crossref
Daniel Alameda, Borja Saez, David Lara-Astiaso, Sarai Sarvide, Marta Lasa, Diego Alignani, Idoia Rodriguez, Sonia Garate, Amaia Vilas, Bruno Paiva, Matias Alfonso-Olmos, Jose Maria Lamo De Espinosa, Felipe Prosper, Jesus F. San Miguel & Patricia Maiso. (2020) Characterization of freshly isolated bone marrow mesenchymal stromal cells from healthy donors and patients with multiple myeloma: transcriptional modulation of the microenvironment. Haematologica 105:9, pages e470-473.
Crossref
Crossref
Hayoung Choi, Yonggoo Kim, Dain Kang, Ahlm Kwon, Jiyeon Kim, Jung Min Kim, Sung‐Soo Park, Yoo‐Jin Kim, Chang‐Ki Min & Myungshin Kim. (2020) Common and different alterations of bone marrow mesenchymal stromal cells in myelodysplastic syndrome and multiple myeloma. Cell Proliferation 53:5.
Crossref
Crossref
Renza Spelat, Federico Ferro, Paolo Contessotto, Nicholas J. Warren, Grazia Marsico, Steven P. Armes & Abhay Pandit. (2020) A worm gel-based 3D model to elucidate the paracrine interaction between multiple myeloma and mesenchymal stem cells. Materials Today Bio 5, pages 100040.
Crossref
Crossref
Alessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, Marta Pugliese, Eleonora Di Salvo, Elvira Ventura-Spagnolo, Caterina Musolino & Sebastiano Gangemi. (2019) Lymphocyte Subsets and Inflammatory Cytokines of Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma. International Journal of Molecular Sciences 20:11, pages 2822.
Crossref
Crossref
Véronique Béréziat, Christelle Mazurier, Martine Auclair, Nathalie Ferrand, Séverine Jolly, Tiffany Marie, Ladan Kobari, Indira Toillon, François Delhommeau, Bruno Fève, Annette K. Larsen, Michèle Sabbah & Laurent Garderet. (2019) Systemic Dysfunction of Osteoblast Differentiation in Adipose-Derived Stem Cells from Patients with Multiple Myeloma. Cells 8:5, pages 441.
Crossref
Crossref
Ximena Bonilla, Natalia-Del Pilar Vanegas & Jean Paul Vernot. (2019) Acute Leukemia Induces Senescence and Impaired Osteogenic Differentiation in Mesenchymal Stem Cells Endowing Leukemic Cells with Functional Advantages. Stem Cells International 2019, pages 1-16.
Crossref
Crossref
Olga Blau, Rimma Berenstein, Marlies Wächter, Axel Nogai, Aline Künel, Mirgul Bayanova & Igor Wolfgang Blau. 2019. Stromal Cells - Structure, Function, and Therapeutic Implications. Stromal Cells - Structure, Function, and Therapeutic Implications.
Eoin P. McNeill, Robert W. Reese, Abishek Tondon, Bret H. Clough, Simin Pan, Jeremiah Froese, Daniel Palmer, Ulf Krause, David M. Loeb, Roland Kaunas & Carl A. Gregory. (2018) Three-dimensional in vitro modeling of malignant bone disease recapitulates experimentally accessible mechanisms of osteoinhibition. Cell Death & Disease 9:12.
Crossref
Crossref
Juraj Adamik, Deborah L Galson & G David Roodman. (2018) Osteoblast suppression in multiple myeloma bone disease. Journal of Bone Oncology 13, pages 62-70.
Crossref
Crossref
Shokichi Tsukamoto, Marianne B. Løvendorf, Jihye Park, Karma Z. Salem, Michaela R. Reagan, Salomon Manier, Oksana Zavidij, Mahshid Rahmat, Daisy Huynh, Satoshi Takagi, Yawara Kawano, Katsutoshi Kokubun, Charlotte Albæk Thrue, Kenichi Nagano, Andreas Petri, Aldo M. Roccaro, Marzia Capelletti, Roland Baron, Sakari Kauppinen & Irene M. Ghobrial. (2018) Inhibition of microRNA-138 enhances bone formation in multiple myeloma bone marrow niche. Leukemia 32:8, pages 1739-1750.
Crossref
Crossref
Song Xu, Kim De Veirman, Ann De Becker, Karin Vanderkerken & Ivan Van Riet. (2018) Mesenchymal stem cells in multiple myeloma: a therapeutical tool or target?. Leukemia 32:7, pages 1500-1514.
Crossref
Crossref
Sarah M. Ridge, Dibyangana Bhattacharyya, Eoin Dervan, Serika D. Naicker, Amy J. Burke, J.M. Murphy, Karen O'leary, John Greene, Aideen E. Ryan, Francis J. Sullivan & Sharon A. Glynn. (2018) Secreted factors from metastatic prostate cancer cells stimulate mesenchymal stem cell transition to a pro‐tumourigenic ‘activated’ state that enhances prostate cancer cell migration. International Journal of Cancer 142:10, pages 2056-2067.
Crossref
Crossref
Jerome T. Higgs, Joo Hyoung Lee, Hong Wang, Vishnu C. Ramani, Diptiman Chanda, Cherlene Y. Hardy, Ralph D. Sanderson & Selvarangan Ponnazhagan. (2017) Mesenchymal stem cells expressing osteoprotegerin variants inhibit osteolysis in a murine model of multiple myeloma. Blood Advances 1:25, pages 2375-2385.
Crossref
Crossref
Juraj Adamik, Shunqian Jin, Quanhong Sun, Peng Zhang, Kurt R. Weiss, Judith L. Anderson, Rebecca Silbermann, G. David Roodman & Deborah L. Galson. (2017) EZH2 or HDAC1 Inhibition Reverses Multiple Myeloma–Induced Epigenetic Suppression of Osteoblast Differentiation. Molecular Cancer Research 15:4, pages 405-417.
Crossref
Crossref
G McNee, K L Eales, W Wei, D S Williams, A Barkhuizen, D B Bartlett, S Essex, S Anandram, A Filer, P A H Moss, G Pratt, S Basu, C C Davies & D A Tennant. (2016) Citrullination of histone H3 drives IL-6 production by bone marrow mesenchymal stem cells in MGUS and multiple myeloma. Leukemia 31:2, pages 373-381.
Crossref
Crossref
M. Qayed, I. Copland & J. Galipeau. 2017. Mesenchymal Stromal Cells. Mesenchymal Stromal Cells
97
120
.
Cesarina Giallongo, Daniele Tibullo, Nunziatina L. Parrinello, Piera La Cava, Michelino Di Rosa, Vincenzo Bramanti, Cosimo Di Raimondo, Concetta Conticello, Annalisa Chiarenza, Giuseppe A. Palumbo, Roberto Avola, Alessandra Romano & Francesco Di Raimondo. (2016) Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC). Oncotarget 7:52, pages 85764-85775.
Crossref
Crossref
Alessandro Poggi & Massimo Giuliani. (2016) Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment. Vaccines 4:4, pages 41.
Crossref
Crossref
Shirin Ferdowsi, Shirin Azizidoost, Nasim Ghafari & Najmaldin Saki. (2016) Cytogenetic changes of mesenchymal stem cells in the neoplastic bone marrow niche in leukemia. Frontiers in Biology 11:4, pages 305-310.
Crossref
Crossref
G. Shay, L. Hazlehurst & C. C. Lynch. (2015) Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities. Journal of Molecular Medicine 94:1, pages 21-35.
Crossref
Crossref
Rimma Berenstein, Olga Blau, Axel Nogai, Marlies Waechter, Ekaterina Slonova, Martin Schmidt-Hieber, Annegret Kunitz, Antonio Pezzutto, Bernd Doerken & Igor Wolfgang Blau. (2015) Multiple myeloma cells alter the senescence phenotype of bone marrow mesenchymal stromal cells under participation of the DLK1-DIO3 genomic region. BMC Cancer 15:1.
Crossref
Crossref
Ana Entrena, Alberto Varas, Miriam Vázquez, Gustavo J. Melen, Lidia M. Fernández-Sevilla, Javier García-Castro, Manuel Ramírez, Agustín G. Zapata & Ángeles Vicente. (2015) Mesenchymal stem cells derived from low risk acute lymphoblastic leukemia patients promote NK cell antitumor activity. Cancer Letters 363:2, pages 156-165.
Crossref
Crossref
Wenzhuo Zhuang, Xueping Ge, Sijun Yang, Moli Huang, Wenyue Zhuang, Ping Chen, Xiaohui Zhang, Jinxiang Fu, Jing Qu & Bingzong Li. (2015) Upregulation of lncRNA MEG3 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells From Multiple Myeloma Patients By Targeting BMP4 Transcription. Stem Cells 33:6, pages 1985-1997.
Crossref
Crossref
Dong Soon Choi, Daniel J. Stark, Robert M. Raphael, Jianguo Wen, Jing Su, Xiaobo Zhou, Chung-Che Chang & Youli Zu. (2015) SDF-1α stiffens myeloma bone marrow mesenchymal stromal cells through the activation of RhoA-ROCK-Myosin II. International Journal of Cancer 136:5, pages E219-E229.
Crossref
Crossref
Matthew T Drake. (2014) Unveiling Skeletal Fragility in Patients Diagnosed With MGUS: No Longer a Condition of Undetermined Significance?. Journal of Bone and Mineral Research 29:12, pages 2529-2533.
Crossref
Crossref
Deepika Kassen, Sally Moore, Laura Percy, Gaelle Herledan, Danton Bounds, Manuel Rodriguez-Justo, Peter Croucher & Kwee Yong. (2014)
The bone marrow stromal compartment in multiple myeloma patients retains capability for osteogenic differentiation
in vitro
: defining the stromal defect in myeloma
. British Journal of Haematology 167:2, pages 194-206.
Crossref
Crossref
Antonio Garcia-Gomez, Javier De Las Rivas, Enrique M. Ocio, Elena Díaz-Rodríguez, Juan C. Montero, Montserrat Martín, Juan F. Blanco, Fermín M. Sanchez-Guijo, Atanasio Pandiella, Jesús F. San Miguel & Mercedes Garayoa. (2014) Transcriptomic profile induced in bone marrow mesenchymal stromal cells after interaction with multiple myeloma cells: implications in myeloma progression and myeloma bone disease. Oncotarget 5:18, pages 8284-8305.
Crossref
Crossref
Hsiu-Hsia Lin, Shiaw-Min Hwang, Shang-Ju Wu, Lee-Feng Hsu, Yi-Hua Liao, Yi-Shuan Sheen, Wen-Hui Chuang & Shang-Yi Huang. (2014) The Osteoblastogenesis Potential of Adipose Mesenchymal Stem Cells in Myeloma Patients Who Had Received Intensive Therapy. PLoS ONE 9:4, pages e94395.
Crossref
Crossref
Antonio Garcia-Gomez. (2014) Multiple myeloma mesenchymal stromal cells: Contribution to myeloma bone disease and therapeutics. World Journal of Stem Cells 6:3, pages 322.
Crossref
Crossref
Asim Khwaja, John Quinn & Kwee L. Yong. 2013. Myeloma. Myeloma
64
83
.
Song Xu, Gaia Cecilia Santini, Kim De Veirman, Isabelle Vande Broek, Xavier Leleu, Ann De Becker, Ben Van Camp, Karin Vanderkerken & Ivan Van Riet. (2013) Upregulation of miR-135b Is Involved in the Impaired Osteogenic Differentiation of Mesenchymal Stem Cells Derived from Multiple Myeloma Patients. PLoS ONE 8:11, pages e79752.
Crossref
Crossref
Fuling Zhou, Shan Meng, Huanjin Song & François X. Claret. (2013) Dickkopf-1 is a key regulator of myeloma bone disease: Opportunities and challenges for therapeutic intervention. Blood Reviews 27:6, pages 261-267.
Crossref
Crossref
Jin Wang, Lianming Liao, Shuiliang Wang & Jianming Tan. (2013) Cell therapy with autologous mesenchymal stem cells—how the disease process impacts clinical considerations. Cytotherapy 15:8, pages 893-904.
Crossref
Crossref
Thibaud André, Nathalie Meuleman, Basile Stamatopoulos, Cécile De Bruyn, Karlien Pieters, Dominique Bron & Laurence Lagneaux. (2013) Evidences of Early Senescence in Multiple Myeloma Bone Marrow Mesenchymal Stromal Cells. PLoS ONE 8:3, pages e59756.
Crossref
Crossref
S Xu, H Evans, C Buckle, K De Veirman, J Hu, D Xu, E Menu, A De Becker, I Vande Broek, X Leleu, B V Camp, P Croucher, K Vanderkerken & I Van Riet. (2012) Impaired osteogenic differentiation of mesenchymal stem cells derived from multiple myeloma patients is associated with a blockade in the deactivation of the Notch signaling pathway. Leukemia 26:12, pages 2546-2549.
Crossref
Crossref
J E Noll, S A Williams, L E Purton & A C W Zannettino. (2012) Tug of war in the haematopoietic stem cell niche: do myeloma plasma cells compete for the HSC niche?. Blood Cancer Journal 2:9, pages e91-e91.
Crossref
Crossref
Meirav Pevsner-Fischer, Sarit Levin, Tal Hammer-Topaz, Yifat Cohen, Felix Mor, Gerard Wagemaker, Arnon Nagler, Irun Robert Cohen & Dov Zipori. (2011) Stable Changes in Mesenchymal Stromal Cells from Multiple Myeloma Patients Revealed through Their Responses to Toll-Like Receptor Ligands and Epidermal Growth Factor. Stem Cell Reviews and Reports 8:2, pages 343-354.
Crossref
Crossref
Antonio Garcia-Gomez, Enrique M. Ocio, Edvan Crusoe, Carlos Santamaria, Pilar Hernández-Campo, Juan F. Blanco, Fermin M. Sanchez-Guijo, Teresa Hernández-Iglesias, Jesús G. Briñón, Rosa M. Fisac-Herrero, Francis Y. Lee, Atanasio Pandiella, Jesús F. San Miguel & Mercedes Garayoa. (2012) Dasatinib as a Bone-Modifying Agent: Anabolic and Anti-Resorptive Effects. PLoS ONE 7:4, pages e34914.
Crossref
Crossref
Michaela R. Reagan & Irene M. Ghobrial. (2012) Multiple Myeloma Mesenchymal Stem Cells: Characterization, Origin, and Tumor-Promoting Effects. Clinical Cancer Research 18:2, pages 342-349.
Crossref
Crossref
T. Lee. 2012. Progenitor and Stem Cell Technologies and Therapies. Progenitor and Stem Cell Technologies and Therapies
345
390
.
Ivetta Danylesko, Katia Beider, Avichai Shimoni & Arnon Nagler. (2012) Novel Strategies for Immunotherapy in Multiple Myeloma: Previous Experience and Future Directions. Clinical and Developmental Immunology 2012, pages 1-28.
Crossref
Crossref
Hong Yang, Simon N. Robinson, Yago Nieto, Richard J. Jones, Christopher D. Gocke, Junjun Lu, Sergio A. Giralt, Roy B. Jones, William K. Decker, Dongxia Xing, David Steiner, Richard E. Champlin, John D. McMannis, Jingjing Ng, Michael W. Thomas, Nina Shah, Borje S. Andersson, Simrit Parmar & Elizabeth J. Shpall. (2011)
Ex Vivo
Graft Purging and Expansion of Autologous Blood Progenitor Cell Products from Patients with Multiple Myeloma
. Cancer Research 71:14, pages 5040-5049.
Crossref
Crossref
W. Grady Gunn, Ulf Krause, Narae Lee & Carl A. Gregory. (2011) Pharmaceutical inhibition of glycogen synthetase kinase-3β reduces multiple myeloma–induced bone disease in a novel murine plasmacytoma xenograft model. Blood 117:5, pages 1641-1651.
Crossref
Crossref
Jessica A. Fowler, Claire M. Edwards & Peter I. Croucher. (2011) Tumor–host cell interactions in the bone disease of myeloma. Bone 48:1, pages 121-128.
Crossref
Crossref
Xiaoyi Dun, Hua Jiang, Jianfeng Zou, Jun Shi, Lili Zhou, Rong Zhu & Jian Hou. (2010) Differential expression of DKK-1 binding receptors on stromal cells and myeloma cells results in their distinct response to secreted DKK-1 in myeloma. Molecular Cancer 9:1.
Crossref
Crossref
Jia-Yin Xie, Meng-Xia Li, De-Bing Xiang, Jiang-Hong Mou, Yi Qing, Lin-Li Zeng, Zhen-Zhou Yang, Wei Guan & Dong Wang. (2010) Elevated Expression of APE1/Ref-1 and its Regulation on IL-6 and IL-8 in Bone Marrow Stromal Cells of Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 10:5, pages 385-393.
Crossref
Crossref
Yongdong Feng, Gidon Ofek, Dong Soon Choi, Jianguo Wen, Jerry Hu, Hong Zhao, Youli Zu, Kyriacos A. Athanasiou & Chung-Che Chang. (2010) Unique biomechanical interactions between myeloma cells and bone marrow stroma cells. Progress in Biophysics and Molecular Biology 103:1, pages 148-156.
Crossref
Crossref
Mark S Nanes. (2010) Preventing metastases to bone: Denosumab or bisphosphonates?. Journal of Bone and Mineral Research 25:3, pages 437-439.
Crossref
Crossref
Katia Todoerti, Gina Lisignoli, Paola Storti, Luca Agnelli, Francesca Novara, Cristina Manferdini, Katia Codeluppi, Simona Colla, Monica Crugnola, Manuela Abeltino, Marina Bolzoni, Valentina Sgobba, Andrea Facchini, Giorgio Lambertenghi-Deliliers, Orsetta Zuffardi, Vittorio Rizzoli, Antonino Neri & Nicola Giuliani. (2010) Distinct transcriptional profiles characterize bone microenvironment mesenchymal cells rather than osteoblasts in relationship with multiple myeloma bone disease. Experimental Hematology 38:2, pages 141-153.
Crossref
Crossref
Nicola Giuliani. 2010. Myeloma Bone Disease. Myeloma Bone Disease
231
242
.
Claire M. Edwards & Gregory R. Mundy. 2010. Myeloma Bone Disease. Myeloma Bone Disease
211
229
.
David Zisa, Arsalan Shabbir, Gen Suzuki & Techung Lee. (2009) Vascular endothelial growth factor (VEGF) as a key therapeutic trophic factor in bone marrow mesenchymal stem cell-mediated cardiac repair. Biochemical and Biophysical Research Communications 390:3, pages 834-838.
Crossref
Crossref
M Garayoa, J L Garcia, C Santamaria, A Garcia-Gomez, J F Blanco, A Pandiella, J M Hernández, F M Sanchez-Guijo, M-C del Cañizo, N C Gutiérrez & J F San Miguel. (2009) Mesenchymal stem cells from multiple myeloma patients display distinct genomic profile as compared with those from normal donors. Leukemia 23:8, pages 1515-1527.
Crossref
Crossref
Nicola Giuliani, Marcellina Mangoni & Vittorio Rizzoli. (2009) Osteogenic differentiation of mesenchymal stem cells in multiple myeloma: Identification of potential therapeutic targets. Experimental Hematology 37:8, pages 879-886.
Crossref
Crossref